Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...

Discover top medications for 'treating Benign Prostatic ... Benign Prostatic Hyperplasia (BPH) or Benign Enlargement of Prostate (BEP) is an increase in the size of the prostate.

BPH isn't prostate cancer and doesn't make you more likely to get it. There are many treatments for it, from lifestyle changes to medication to surgery. (Photo Credit: iStock/Getty Images ...

The Italian national drug database includes the prescriptions ... Patients were followed until hospitalization or surgery for BPH occurred or until their last follow-up. Patients were excluded ...

Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) symptoms ...

In this study we demonstrated that in "real life" patient adherence to BPH medication is different to that reported in clinical trials and that patients under CT abandon treatment more frequently ...

They say the drug might slow Parkinson's progression - something that is not possible currently. They studied thousands of patients with both BPH and Parkinson's. Their findings, published in the ...

On Tuesday, BHP's market value was about £128bn, second in size in the FTSE 100 only to drugs firm AstraZeneca, which is worth about £131bn. BHP is the biggest company on the Australian stock ...